| Literature DB >> 35697447 |
Vu Quoc Dat1, Bui Thi Khanh Linh2, Giang Bao Kim3.
Abstract
OBJECTIVE: The goal of this study was to describe the burden of disease and in-hospital mortality among patients admitted to the critical care units (CCUs) in Vietnam.Entities:
Keywords: adult intensive & critical care; epidemiology; public health
Mesh:
Year: 2022 PMID: 35697447 PMCID: PMC9196179 DOI: 10.1136/bmjopen-2022-061638
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Flow chart of CCU admission and outcome. CCU, critical care unit.
Figure 2Diagnosis on admission to CCU by age groups. CCU, critical care unit.
Figure 3Number of admission and In-hospital mortality by age groups.
Figure 4Cause of admission to CCUs by level of care. CCU, critical care unit.
The top 20 causes of death in terms of years of life lost (YLL) and numbers of deaths by ICD-11 block level one codes
| Diagnosis | No and proportion of death cases | In-hospital mortality (n,%) | Total YLL75 | Proportion of YLLs75 | YLL75 per 1000 patients | Length of stay to death (median, IQR) |
| Cerebrovascular diseases | 303 (18.0%) | 8.7% | 3 211 000 | 12.3% | 1380 | 3 (2–6) |
| Miscellaneous | 259 (15.4%) | 2.3% | 5 686 000 | 38.2% | 614 | 2 (1–6) |
| Lung infections | 201 (12.0%) | 7.2% | 2 875 000 | 9.5% | 1440 | 7 (3–15) |
| Sepsis | 149 (8.9%) | 36.8% | 1 991 000 | 2.6% | 8127 | 4 (2–11) |
| Harmful effects of substances | 87 (5.2%) | 6.1% | 3 534 000 | 5.0% | 2544 | 1 (1–2) |
| Respiratory failure | 79 (4.7%) | 18.1% | 365 000 | 1.6% | 1714 | 9 (5–15) |
| General symptoms, signs or clinical findings | 67 (4.0%) | 13.5% | 1 507 000 | 2.2% | 3712 | 2 (1–4.5) |
| Injuries to the head | 66 (3.9%) | 15.6% | 1 140 000 | 1.6% | 3167 | 2 (2–4) |
| Certain lower respiratory tract diseases | 63 (3.7%) | 2.1% | 443 000 | 10.2% | 217 | 4 (2–10) |
| Symptoms, signs or clinical findings of the digestive system or abdomen | 61 (3.6%) | 5.5% | 994 000 | 4.0% | 1062 | 3 (2–6) |
| Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related | 50 (3.0%) | 18.0% | 587 000 | 1.0% | 3073 | 6 (3–9) |
| Symptoms, signs or clinical findings of the circulatory system | 50 (3.0%) | 31.8% | 1 060 000 | 0.7% | 8217 | 2 (1–6) |
| Heart failure | 39 (2.3%) | 8.4% | 280 000 | 1.6% | 1466 | 3 (1–5) |
| Ischaemic heart diseases | 37 (2.2%) | 5.2% | 78 000 | 2.5% | 158 | 3 (1–5) |
| Diseases of liver | 36 (2.1%) | 11.2% | 549 000 | 1.1% | 1861 | 2.5 (1.5–7.5) |
| Injuries involving multiple body regions | 29 (1.7%) | 28.2% | 439 000 | 0.4% | 6362 | 2 (1–6) |
| Symptoms, signs or clinical findings of the respiratory system | 28 (1.7%) | 8.4% | 706 000 | 1.1% | 3017 | 2 (1–4) |
| Mental or behavioural symptoms, signs or clinical findings | 22 (1.3%) | 13.3% | 363 000 | 0.8% | 2771 | 2 (1–2) |
| Allergic or hypersensitivity conditions | 20 (1.2%) | 3.3% | 890 000 | 2.2% | 1537 | 2 (1–2) |
| Infection, unspecified | 19 (1.1%) | 31.7% | 741 000 | 0.2% | 14 529 | 2 (2–4) |
| Epilepsy or seizures | 16 (1.0%) | 5.0% | 696 000 | 1.1% | 2275 | 1.5 (1–2) |
| Total | 1681 (100.0%) | 5.9% | 28 135 000 | 100.0% | 1287 | 3 (2–7) |
ICD, International Classification of Disease.